Steven Devine
Overview
Explore the profile of Steven Devine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
2585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaur M, Horowitz M, Mendizabal A, Chen M, Foley A, Auletta J, et al.
Transplant Cell Ther
. 2024 Nov;
31(1):49-57.
PMID: 39489220
Underrepresentation by race and ethnicity in oncology clinical trials, including those of hematopoietic cell transplantation (HCT), is a known challenge. This analysis studied accrual on Blood and Marrow Transplant Clinical...
2.
Dehn J, Logan B, Shaw B, Devine S, Ciurea S, Horowitz M, et al.
medRxiv
. 2024 Oct;
PMID: 39371123
Importance: Patients requiring allogeneic hematopoietic cell transplantation have variable likelihoods of identifying an 8/8 HLA-matched unrelated donor. A Search Prognosis calculator can estimate the likelihood. Objective: To determine if using...
3.
Bhatt N, Meyer C, Mau L, Auletta J, Baker K, Broglie L, et al.
Bone Marrow Transplant
. 2024 Feb;
59(5):653-659.
PMID: 38378916
To understand transplant center recommendations on return-to-school timing and related support for hematopoietic cell transplant (HCT) survivors, we conducted a two-phase, cross-sectional, web-based survey: In Phase I, medical directors of...
4.
Nakamura R, La Rosa C, Yang D, Hill J, Rashidi A, Choe H, et al.
Haematologica
. 2024 Feb;
109(6):1994-1999.
PMID: 38328852
No abstract available.
5.
Miller A, Davies J, Young K, Eckman E, Lo M, Erskine H, et al.
Transfusion
. 2023 Sep;
63(10):1926-1936.
PMID: 37668194
Background: Optimizing CD34 recovery while minimizing harm to hematopoietic progenitor cell donors by apheresis (HPC(A) donors) is critical to the success of allogeneic hematopoietic cell transplantation. We examined the efficacy...
6.
Magenau J, Jaglowski S, Uberti J, Farag S, Riwes M, Pawarode A, et al.
Blood
. 2023 Aug;
143(1):21-31.
PMID: 37647633
Patients who undergo human leukocyte antigen-matched unrelated donor (MUD) allogeneic hematopoietic stem cell transplantation (HSCT) with myeloablative conditioning for hematologic malignancies often develop acute graft-versus-host disease (GVHD) despite standard calcineurin...
7.
Maziarz R, Devine S, Garrison L, Agodoa I, Badaracco J, Gitlin M, et al.
Transplant Cell Ther
. 2023 Jun;
29(10):637.e1-637.e9.
PMID: 37364775
Allogeneic hematopoietic cell transplantation (allo-HCT) has the potential for curative outcomes for a variety of hematologic malignancies. Current allo-HCT studies often describe the outcomes and costs in the near term;...
8.
Chakraborty R, Yi J, Rybicki L, Preussler J, Deol A, Loren A, et al.
Transplant Cell Ther
. 2023 Mar;
29(6):388.e1-388.e6.
PMID: 36870388
The overall survival in patients with transplantation-eligible multiple myeloma has tripled over the past 2 decades, leading to a growing population of myeloma survivors. However, there is a paucity of...
9.
Guru Murthy G, Logan B, Bo-Subait S, Beitinjaneh A, Devine S, Farhadfar N, et al.
Am J Hematol
. 2023 Jan;
98(4):608-619.
PMID: 36606713
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). While many factors influence the outcomes of allo-HCT, the independent...
10.
Hong S, Zhao J, Wang S, Wang H, Lee J, Farhadfar N, et al.
Transplant Cell Ther
. 2022 Nov;
29(3):202.e1-202.e8.
PMID: 36427784
The use of hematopoietic cell transplantation (HCT) has been increasing in older patients. However, the levels if distress, psychosocial functioning, and health-related quality of life (HRQOL) among older HCT survivors...